Partial Seizures

13 registered clinical trials studyying Partial Seizures.

Status	Trial	Sponsor	Phase
Completed	A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Sub NCT03340064	UCB Japan Co. Ltd.	Phase 3
Completed	A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures NCT04257604	Eisai Limited	—
Completed	Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seiz NCT01954121	UCB Pharma SA	Phase 3
Completed	Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization NCT01392768	Ache Laboratorios Farmaceuticos S.A.	Phase 3
Completed	Once-A-Day Pregabalin For Partial Seizures NCT01262677	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures NCT01063764	UCB Japan Co. Ltd.	Phase 3
Completed	Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Adde NCT01630057	Eisai Inc.	Phase 4
Completed	A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ NCT01136954	Eisai Limited	Phase 3
Completed	Pregabalin Versus Levetiracetam In Partial Seizures NCT00537238	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Terminated	Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial NCT00407797	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures NCT00327717	Eisai Inc.	Phase 3
Completed	Pregabalin Epilepsy Add-On Trial NCT00141258	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	A Study for Treatment of Partial Seizures in Children NCT00102713	Abbott	Phase 3